A smart and versatile theranostic nanomedicine platform based on nanoporphyrin

Nature Communications

Volumn 5, Issue , 2014, Pages

  Li, Yuanpei ^a   Lin, Tzu Yin ^b   Luo, Yan ^a,c   Liu, Qiangqiang ^a,d   Xiao, Wenwu ^a   Guo, Wenchang ^a   Lac, Diana ^a   Zhang, Hongyong ^b   Feng, Caihong ^a,e   Wachsmann Hogiu, Sebastian ^a,b   Walton, Jeffrey H ^a   Cherry, Simon R ^f   Rowland, Douglas J ^f   Kukis, David ^f   Pan, Chongxian ^b,g   Lam, Kit S ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

^d SICHUAN UNIVERSITY   (China)

^e BEIJING INSTITUTE OF TECHNOLOGY   (China)

^f University of California   (United States)

^g VA NORTHERN CALIFORNIA HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; NANOCARRIER; SINGLET OXYGEN; DENDRIMER; DRUG CARRIER; NANOMATERIAL; PORPHYRIN; REACTIVE OXYGEN METABOLITE;

NANOTECHNOLOGY; NEAR INFRARED; OXYGEN; POLYMER; PROBE; TUMOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CANCER CELL LINE; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG STABILITY; FEMALE; FLUORESCENCE IMAGING; HUMAN; LIGHT; MALE; MASS SPECTROMETRY; MOUSE; NANOMEDICINE; NANOPROBE; NEAR INFRARED SPECTROSCOPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARIAN CANCER CELL LINE; PHOTODYNAMIC THERAPY; PHOTOTHERAPY; POSITRON EMISSION TOMOGRAPHY; PROSTATE CANCER CELL LINE; RAT; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; BLOOD; CHEMISTRY; DEVICES; DRUG EFFECTS; FLUORESCENCE; METABOLISM; NUDE MOUSE; PHOTOCHEMOTHERAPY; PROCEDURES; SPRAGUE DAWLEY RAT; THERANOSTIC NANOMEDICINE; TRANSGENIC MOUSE; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; DENDRIMERS; DOXORUBICIN; DRUG CARRIERS; FEMALE; FLUORESCENCE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MICE, NUDE; MICE, TRANSGENIC; NANOSTRUCTURES; PHOTOCHEMOTHERAPY; PORPHYRINS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SPECTROSCOPY, NEAR-INFRARED; THERANOSTIC NANOMEDICINE;

EID: 84907331699     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms5712     Document Type: Article

References (54)

1. Lee, D. E. et al. Multifunctional nanoparticles for multimodal imaging and theragnosis. Chem. Soc. Rev. 41, 2656-2672 (2012).
2. Xie, J., Lee, S. & Chen, X. Nanoparticle-based theranostic agents. Adv. Drug Deliv. Rev. 62, 1064-1079 (2010).
3. Choi, K. Y., Liu, G., Lee, S. & Chen, X. Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives. Nanoscale 4, 330-342 (2012).
4. Luk, B. T., Fang, R. H. & Zhang, L. Lipid-and polymer-based nanostructures for cancer theranostics. Theranostics 2, 1117-1126 (2012).
5. Pan, D. Theranostic nanomedicine with functional nanoarchitecture. Mol. Pharm. 10, 781-782 (2013).
6. Chen, X., Gambhir, S. S. & Cheon, J. Theranostic nanomedicine. Acc. Chem. Res. 44, 841 (2011).
7. Lovell, J. F. et al. Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents. Nat. Mater. 10, 324-332 (2011).
8. Qi, L. & Gao, X. Emerging application of quantum dots for drug delivery and therapy. Exp. Opin. Drug Deliv. 5, 263-267 (2008).
9. Mahmoudi, M., Sant, S., Wang, B., Laurent, S. & Sen, T. Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. Adv. Drug Deliv. Rev. 63, 24-46 (2011).
10. Laurent, S. et al. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem. Rev. 108, 2064-2110 (2008).
11. Demberelnyamba, D., Ariunaa, M. & Shim, Y. K. Newly synthesized water soluble cholinium-purpurin photosensitizers and their stabilized gold nanoparticles as promising anticancer agents. Int. J. Mol. Sci. 9, 864-871 (2008).
12. von Maltzahn, G. et al. Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. Cancer Res. 69, 3892-3900 (2009).
13. Singh, N., Jenkins, G. J., Asadi, R. & Doak, S. H. Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Rev. 1 doi: 10.3402/nano.v1i0.5358 (2010).
14. Cheng, L., Yang, K., Chen, Q. & Liu, Z. Organic stealth nanoparticles for highly effective in vivo near-infrared photothermal therapy of cancer. ACS Nano 6, 5605-5613 (2012).
15. Cabral, H. et al. Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. Nat. Nanotech. 6, 815-823 (2011).
16. Luo, J. et al. Well-defined, size-tunable, multifunctional micelles for efficient paclitaxel delivery for cancer treatment. Bioconjug. Chem. 21, 1216-1224 (2010).
17. Chauhan, V. P. et al. Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner. Nat. Nanotech. 7, 383-388 (2012).
18. Zhou, K. et al. Multicolored pH-tunable and activatable fluorescence nanoplatform responsive to physiologic pH stimuli. J. Am. Chem. Soc. 134, 7803-7811 (2012).
19. Li, Y. et al. Probing of the assembly structure and dynamics within nanoparticles during interaction with blood proteins. ACS nano 6, 9485-9495 (2012).
20. Wu, D. Q. et al. Porphyrin and galactosyl conjugated micelles for targeting photodynamic therapy. Pharm. Res. 27, 187-199 (2010).
21. Li, Y. et al. Well-defined, reversible disulfide cross-linked micelles for on-demand paclitaxel delivery. Biomaterials 32, 6633-6645 (2011).
22. Xiao, K. et al. The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles. Biomaterials 32, 3435-3446 (2011).
23. Li, Y. et al. Well-defined, reversible boronate crosslinked nanocarriers for targeted drug delivery in response to acidic pH values and cis-diols. Angew. Chem. Int. Ed. 51, 2864-2869 (2012).
24. Li, Y. et al. A novel size-tunable nanocarrier system for targeted anticancer drug delivery. J. Control Release 144, 314-323 (2010).
25. Kato, J. et al. Disulfide cross-linked micelles for the targeted delivery of vincristine to B-cell lymphoma. Mol. Pharm. 9, 1727-1735 (2012).
26. Rong, P. et al. Photosensitizer loaded nano-graphene for multimodality imaging guided tumor photodynamic therapy. Theranostics 4, 229-239 (2014).
27. Ng, K. K., Lovell, J. F., Vedadi, A., Hajian, T. & Zheng, G. Self-assembled porphyrin nanodiscs with structure-dependent activation for phototherapy and photodiagnostic applications. ACS Nano 7, 3484-3490 (2013).
28. Matsumoto, S. et al. Environment-responsive block copolymer micelles with a disulfide cross-linked core for enhanced siRNA delivery. Biomacromolecules 10, 119-127 (2009).
29. Xiao, K. et al. PEG-oligocholic acid telodendrimer micelles for the targeted delivery of doxorubicin to B-cell lymphoma. J. Control Release 155, 272-281 (2011).
30. Bui, T. et al. Novel Gd nanoparticles enhance vascular contrast for highresolution magnetic resonance imaging. PLoS ONE 5 (2010).
31. Judenhofer, M. S. et al. Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat. Med. 14, 459-465 (2008).
32. Catana, C. et al. Simultaneous in vivo positron emission tomography and magnetic resonance imaging. Proc. Natl Acad. Sci. USA 105, 3705-3710 (2008).
33. Torres Martin de Rosales, R. et al. Synthesis of 64Cu(II)- bis(dithiocarbamatebisphosphonate) and its conjugation with superparamagnetic iron oxide nanoparticles: in vivo evaluation as dualmodality PET-MRI agent. Angew. Chem. Int. Ed. 50, 5509-5513 (2011).
34. Choi, J. S. et al. A hybrid nanoparticle probe for dual-modality positron emission tomography and magnetic resonance imaging. Angew. Chem. Int. Ed. 47, 6259-6262 (2008).
35. Lee, H. Y. et al. PET/MRI dual-modality tumor imaging using arginine-glycineaspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles. J. Nucl. Med. 49, 1371-1379 (2008).
36. Agostinis, P. et al. Photodynamic therapy of cancer: an update. CA Cancer J. Clin. 61, 250-281 (2011).
37. Jin, C. S., Lovell, J. F., Chen, J. & Zheng, G. Ablation of hypoxic tumors with dose-equivalent photothermal, but not photodynamic, therapy using a nanostructured porphyrin assembly. ACS Nano 7, 2541-2550 (2013).
38. Wang, J. et al. Assembly of aptamer switch probes and photosensitizer on gold nanorods for targeted photothermal and photodynamic cancer therapy. ACS Nano 6, 5070-5077 (2012).
39. Kuo, W. S. et al. Gold nanomaterials conjugated with indocyanine green for dual-modality photodynamic and photothermal therapy. Biomaterials 33, 3270-3278 (2012).
40. Jang, B., Park, J. Y., Tung, C. H., Kim, I. H. & Choi, Y. Gold nanorodphotosensitizer complex for near-infrared fluorescence imaging and photodynamic/photothermal therapy in vivo. ACS Nano 5, 1086-1094 (2011).
41. O'Neal, D. P., Hirsch, L. R., Halas, N. J., Payne, J. D. & West, J. L. Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett. 209, 171-176 (2004).
42. Bardhan, R., Lal, S., Joshi, A. & Halas, N. J. Theranostic nanoshells: from probe design to imaging and treatment of cancer. Acc. Chem. Res. 44, 936-946 (2011).
43. Tian, B., Wang, C., Zhang, S., Feng, L. & Liu, Z. Photothermally enhanced photodynamic therapy delivered by nano-graphene oxide. ACS Nano 5, 7000-7009 (2011).
44. Shi, S. G. et al. Photothermally enhanced photodynamic therapy based on mesoporous Pd@Ag@mSiO(2) nanocarriers. J. Mater. Chem. B 1, 1133-1141 (2013).
45. Cheng, Z., Al Zaki, A., Hui, J. Z., Muzykantov, V. R. & Tsourkas, A. Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities. Science 338, 903-910 (2012).
46. Yang, Z. et al. Long-circulating near-infrared fluorescence core-cross-linked polymeric micelles: synthesis, characterization, and dual nuclear/optical imaging. Biomacromolecules 8, 3422-3428 (2007).
47. Yang, H. et al. Micelles assembled with carbocyanine dyes for theranostic nearinfrared fluorescent cancer imaging and photothermal therapy. Biomaterials 34, 9124-9133 (2013).
48. Michalet, X. et al. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 307, 538-544 (2005).
49. Zhu, D., Liu, F., Ma, L., Liu, D. & Wang, Z. Nanoparticle-based systems for t1-weighted magnetic resonance imaging contrast agents. Int. J. Mol. Sci. 14, 10591-10607 (2013).
50. Jeong, S. Y. et al. Biocompatible polyhydroxyethylaspartamide-based micelles with gadolinium for MRI contrast agents. Nanoscale Res. Lett. 5, 1970-1976 (2010).
51. Idris, N. M. et al. In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers. Nat. Med. 18, 1580-1585 (2012).
52. Xiao, K. et al. 'OA02' peptide facilitates the precise targeting of paclitaxelloaded micellar nanoparticles to ovarian cancer in vivo. Cancer Res. 72, 2100-2110 (2012).
53. Kim, J. K. et al. Gadolinium-chlorin is potentially a new tumor specific MRI contrast agent. Arch. Pharm. Res. 29, 188-190 (2006).
54. Koo, A. N. et al. Disulfide-cross-linked PEG-poly(amino acid)s copolymer micelles for glutathione-mediated intracellular drug delivery. Chem. Commun. 28, 6570-6572 (2008).